Literature DB >> 11242185

Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions.

G C John1, H Sheppard, D Mbori-Ngacha, R Nduati, D Maron, M Reiner, J Kreiss.   

Abstract

PRINCIPLES: HIV-1 in female genital secretions has been measured using swabs, Sno Strips (Akorn, Inc., Buffalo Grove, IL), and cervicovaginal lavage (CVL), but little is known regarding the comparability of these collection techniques.
METHODS: We compared HIV-1 RNA detection and quantity in specimens obtained from HIV-1-seropositive women in Kenya using three sample collection techniques and three storage techniques and evaluated reproducibility in samples collected 5 days apart. Specimens were stored in no medium, freezing medium, or TRI Reagent (Molecular Research Center, Cincinnati, OH) for 2 to 15 months.
RESULTS: HIV-1 RNA assays were conducted on 640 specimens from 20 antiretroviral naive women. Storage in TRI Reagent significantly enhanced detection of genital HIV-1 and yielded significantly higher mean log10 RNA levels than specimens collected in either no or freezing medium. The prevalence of HIV-1 RNA detection in TRI Reagent ranged from 50% to 80% depending on collection method and was highest in cervical swabs. Mean log10 HIV-1 RNA levels were 3.1 log10 copies/cervical swab, 2.6 log10 copies/cervical Sno Strip, 2.5 log10 copies/vaginal swab, 2.4 log10 copies/vaginal Sno Strip, 2.9 log10 copies/ml for cervicovaginal lavage (CVL) cell pellet, and 2.1 log10 copies/ml in CVL supernatant. Comparing specimens from days 1 and 6, there was significant concordance of HIV-1 RNA detection and correlation of HIV-1 RNA levels for cervical swabs, vaginal swabs, vaginal Sno Strips, and CVL cell pellets (kappa, 0.5-0.9; r, 0.5-0.9), but not for cervical Sno Strips or CVL supernatants.
CONCLUSIONS: Cervical or vaginal swab, vaginal Sno Strip, and CVL collection led to reproducible measurement of genital HIV-1 RNA, despite storage for several months and international transport. Collection using swabs was simpler than Sno Strips or cervicovaginal lavage, and yielded the highest prevalence of HIV-1 RNA detection and reproducibility.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242185      PMCID: PMC3372416          DOI: 10.1097/00042560-200102010-00010

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire.

Authors:  P D Ghys; K Fransen; M O Diallo; V Ettiègne-Traoré; I M Coulibaly; K M Yeboué; M L Kalish; C Maurice; J P Whitaker; A E Greenberg; M Laga
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

2.  Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.

Authors:  S B Mostad; J Overbaugh; D M DeVange; M J Welch; B Chohan; K Mandaliya; P Nyange; H L Martin; J Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  Lancet       Date:  1997-09-27       Impact factor: 79.321

3.  Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions.

Authors:  A K Iversen; A R Larsen; T Jensen; L Fugger; U Balslev; S Wahl; J Gerstoft; J I Mullins; P Skinhøj
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

4.  Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency.

Authors:  G C John; R W Nduati; D Mbori-Ngacha; J Overbaugh; M Welch; B A Richardson; J Ndinya-Achola; J Bwayo; J Krieger; F Onyango; J K Kreiss
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

5.  Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women.

Authors:  S C Uvin; A M Caliendo
Journal:  Obstet Gynecol       Date:  1997-11       Impact factor: 7.661

6.  Human immunodeficiency virus type 1 RNA shedding in the female genital tract.

Authors:  C Goulston; W McFarland; D Katzenstein
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

7.  Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract.

Authors:  C E Hart; J L Lennox; M Pratt-Palmore; T C Wright; R F Schinazi; T Evans-Strickfaden; T J Bush; C Schnell; L J Conley; K A Clancy; T V Ellerbrock
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

  7 in total
  14 in total

1.  Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment.

Authors:  Susan M Graham; Linnet Masese; Ruth Gitau; Zahra Jalalian-Lechak; Barbra A Richardson; Norbert Peshu; Kishor Mandaliya; James N Kiarie; Walter Jaoko; Jeckoniah Ndinya-Achola; Julie Overbaugh; R Scott McClelland
Journal:  J Infect Dis       Date:  2010-10-05       Impact factor: 5.226

2.  Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.

Authors:  Alison L Drake; Alison C Roxby; Francisca Ongecha-Owuor; James Kiarie; Grace John-Stewart; Anna Wald; Barbra A Richardson; Jane Hitti; Julie Overbaugh; Sandra Emery; Carey Farquhar
Journal:  J Infect Dis       Date:  2011-12-06       Impact factor: 5.226

3.  Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women.

Authors:  Caroline Mitchell; Kathleen Paul; Kathy Agnew; Reggie Gaussman; Robert W Coombs; Jane Hitti
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

4.  Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.

Authors:  Susan M Graham; Zahra Jalalian-Lechak; Juma Shafi; Vrasha Chohan; Ruth W Deya; Walter Jaoko; Kishor N Mandaliya; Norbert M Peshu; Julie Overbaugh; R Scott McClelland
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

5.  Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.

Authors:  Catherine A Blish; R Scott McClelland; Barbra A Richardson; Walter Jaoko; Kishorchandra Mandaliya; Jared M Baeten; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

6.  Cervical HIV-1 RNA shedding after cryotherapy among HIV-positive women with cervical intraepithelial neoplasia stage 2 or 3.

Authors:  Michael H Chung; Kevin P McKenzie; Barbra A Richardson; Grace C John-Stewart; Robert W Coombs; Hugo De Vuyst; Julia W Njoroge; Evans Nyongesa-Malava; Samah R Sakr; Nelly R Mugo
Journal:  AIDS       Date:  2011-09-24       Impact factor: 4.177

7.  Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection.

Authors:  Charles S Morrison; Korey Demers; Cynthia Kwok; Stanley Bulime; Anne Rinaldi; Marshall Munjoma; Megan Dunbar; Tsungai Chipato; Josaphat Byamugisha; Barbara Van Der Pol; Eric Arts; Robert A Salata
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

8.  Novel methodology for antiretroviral quantitation in the female genital tract.

Authors:  Chantelle Bennetto-Hood; Victoria A Johnson; Jennifer R King; Craig J Hoesley; Edward P Acosta
Journal:  HIV Clin Trials       Date:  2009 May-Jun

9.  Comparison of washing and swabbing procedures for collecting genital fluids to assess shedding of human immunodeficiency virus type 1 (HIV-1) RNA in asymptomatic HIV-1-infected women.

Authors:  Laurent Andréoletti; Gérard Grésenguet; Nicolas Chomont; Mathieu Matta; Yann Quiniou; Ali Si-Mohamed; Laurent Bélec
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Use of Sno Strip filter-paper wicks for collection of genital-tract samples allows reproducible determination of human immunodeficiency virus type 1 (HIV-1) RNA viral load with a commercial HIV-1 viral load assay.

Authors:  Christopher H Sherlock; Paula M Lott; Deborah M Money; Linda Merrick; Yasemin Arikan; Valencia P Remple; Kevin Craib; David R Burdge
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.